Further clinical and laboratory studies with novobiocin. I. Treatment of staphylococcal infections in infancy and childhood. II. Novobiocin concentrations in the blood of newborn infants and in the breast milk of lactating mothers.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000378:metabolism* / Q000627:therapeutic use*; D000904:Antibiotics, Antitubercular; D002648:Child / Q000472:pathogenicity; D005260:Female; D006801:Humans; D007223:Infant / Q000472:pathogenicity; D007231:Infant, Newborn / Q000097:blood; D007774:Lactation; D008837:Micrococcus / Q000472:pathogenicity*; D008892:Milk; D008895:Milk, Human; D009035:Mothers; D009675:Novobiocin; D013203:Staphylococcal Infections
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D009675:Novobiocin
ANTIBIOTICS/metabolism; ANTIBIOTICS/therapeutic use; INFANT, NEWBORN/blood in; MICROCOCCAL INFECTIONS/in infant and child; MILK, HUMAN